The medical test-making company Abbott has finalized its acquisition of Exact Sciences, the Madison-based maker of cancer screening and diagnostic tests, it said in a March 23 announcement. The deal, ...

MADISON, Wis. -- Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said. Madison-based Exact Sciences is known for its cancer detection technology such as ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

To turn engine power into controllable motion, cars rely on something called the differential. A differential allows wheels on the same axle to rotate at different speeds. If you want more information ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. For decades, we came to believe that intelligence was fixed - and we got it wrong. First, it ...

The authors declare no conflicts of interest. [8] M. Younis and A. Zafar, “The Modified Simple Equation Method for Solving Nonlinear Phi-Four Equation,” International Journal of Innovation and Applied ...

Abbott is getting into cancer testing with its $21 billion acquisition Exact Sciences, the maker of the game-changing colorectal cancer test Cologuard. Abbott markets well-known diagnostics for ...

Abbot Laboratory has announced a deal to acquire Madison-based Exact Sciences for approximately $21 billion. Exact Sciences, known for its Cologuard cancer screening test, was founded in 1995 and ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business. This marks one of Abbott's largest deals ...